Seth E. Cockrum, Ph.D.
Dr. Seth E. Cockrum’s practice covers all aspects of patent law, including district court and appellate litigation, post-grant proceedings before the United States Patent Trial and Appeal Board, opinions and counseling. Dr. Cockrum’s litigation practice covers a diverse range of subject matter with a particular focus on Hatch-Waxman litigation. Dr. Cockrum has substantial experience with post-grant proceedings, including patent interferences, inter partes reexaminations, and inter partes reviews. In addition, Dr. Cockrum has experience in drafting and prosecuting domestic patent applications, and in overseeing the prosecution of foreign patent applications.
Dr. Cockrum's technical expertise covers a wide range of chemical and life science disciplines, including organic and inorganic chemistry, small molecule pharmaceuticals, biosimilars, nutraceuticals, herbicides, insecticides, recombinant DNA technology, DNA sequencing, gene silencing, exon skipping, peptide and protein engineering, protein expression, cell culture, drug delivery, molecular biology, and stem cells. In addition to the chemical and life sciences, Dr. Cockrum also has experience in a broader range of technologies including plant biology, material science, medical devices, and computer -related technologies.
Dr. Cockrum graduated with Honors from Butler University with a Bachelor of Science with a double major of Biology and Chemistry. Dr. Cockrum also holds a Ph.D. in Molecular Biology from the University of Texas at Austin. His doctoral work focused on the use of nucleic acid aptamers for both bio-threat detection and therapeutic applications. Dr. Cockrum received his J.D. from the University of Houston Law Center. While in law school, Dr. Cockrum was a member of the Moot Court team, and was inducted into the Order of the Barristers. Dr. Cockrum is a member of the Intellectual Property Section of the ABA, the Intellectual Property Section of the District of Columbia bar, and AIPLA.
Patent and Trademark Office
Interference No. 105,734
Interference No. 105,827
Interference No. 105,922
Interference No. 105,995
Interference No. 106,008
Interference No. 106,012
Interference No. 106,024
Inter Partes Reexamination No. 95/001294
U.S. District Court
Teva Pharmaceuticals USA, Inc. et al. v. Synthon Pharmaceuticals Inc., et al., Civil Action No. 14-1419 (D. Del.)
Cipher Pharmaceuticals, Inc. v. Actavis Laboratories FL, Inc., Civil Action No. 13-6502 (D.N.J.)
Novartis Pharmaceuticals Corp. et al. v. Watson Laboratories, Inc. et al., Civil Action No. 13-371 (D.Del.)
Johns Hopkins University v. 454 Life Sciences Corp., Civil Action No. 13-1853 (D. Del.)
Biogen Idec Ma, Inc., v. Japanese Foundation for Cancer Research et al., Civil Action No. 13-13061 (D. Mass)
Geron Corp. v. ViaCyte, Inc., Civil Action No. 12-4813 (N.D. Cal.)
Cephalon, Inc. v. Mylan Pharmaceuticals Inc., Civil Action No. 11-164 (D. Del.)
The Elations Company LLC v. Osteo Bi-Flex, Civil Action No. 10-219 (S.D. Ohio)
Pfizer Inc. v. Cobalt Laboratories Inc., Civil Action No. 09-00315 (D. Del.)
Sanofi Aventis v. Mylan Pharmaceuticals, Civil Action No. 03-1179 (D.N.J.)
International Trade Commission
In re Lithium Silicate Materials and Products Containing the Same, Investigation No. 337-911